pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT05705427: The COMBAT HBV Feasibility Trial

Sponsor: University of North Carolina, Chapel Hill. Phase: PHASE4. Conditions: Hepatitis B, Vertical Transmission of Infectious Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07272486: The Use of Virtual Reality and Music Therapy for Hypertensive Urgency

Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Hypertensive Urgency, Primary Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07285642: Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Copd

full page →ctgov ↗
›RECRUITINGphase readoutNCT07368270: Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Diffuse Large B Cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05474170: Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest

Sponsor: Geneve TEAM Ambulances. Phase: NA. Conditions: Cardiopulmonary Arrest, Pediatric ALL, Resuscitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07513870: Comparing Inhalational Anesthesia and TIVA on Maternal and Neonatal Hemodynamics in Elective Cesarean Section

Sponsor: Medipol University. Phase: NA. Conditions: Cesarean Section, Anesthesia, General, Anesthesia, Intravenous

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04963283: Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma, Rectum Cancer, Rectal Cancer, Rectal Adenocarcinoma, Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07311083: Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy

Sponsor: Kliniken Essen-Mitte. Phase: NA. Conditions: Microbiome

full page →ctgov ↗
›COMPLETEDphase readoutNCT00506441: A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Kidney Disease, Dialysis, Hyperphosphatemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07423741: Ultrasonographical Assessment of Airway Indices in Pregnancy

Sponsor: South Valley University. Phase: . Conditions: Airway Assessment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07181941: Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE1. Conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05478694: Outcomes of Focal Ablation for Prostate Cancer

Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07161466: Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial

Sponsor: Northern Jiangsu People's Hospital. Phase: NA. Conditions: Dynamic Lung Compliance, Alveolar Recruitment Maneuver

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00544466: Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Leukemia, Myelodysplastic Syndromes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07362550: Effects of 12-Week Balanced Diet on Body Composition & Metabolic Parameters in Twins

Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan. Phase: NA. Conditions: Healthy Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT04802291: HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Healthy Lifestyle, Home Environment Related Disease, Cognitive Change, Child Behavior, Child Obesity, Parenting, Parents, Parent-Child Relations

full page →ctgov ↗
›RECRUITINGphase readoutNCT06575374: Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cell Therapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07109297: Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

Sponsor: Sanofi. Phase: PHASE4. Conditions: RSV Immunization

full page →ctgov ↗
›RECRUITINGphase readoutNCT07150260: Correlation Between Carotid Stump Pressure and Interhemispheric rSO₂ Asymmetry During Awake Carotid Endarterectomy

Sponsor: Izmir Katip Celebi University. Phase: . Conditions: Carotid Artery Stenosis Symptomatic, Carotid Endarterectomy (CEA) Surgical Patients, Cerebral Hypoperfusion

full page →ctgov ↗
›RECRUITINGphase readoutNCT05903560: Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

Sponsor: Jinling Hospital, China. Phase: NA. Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07318220: Prehabilitation Protocol for Head and Neck Cancer Patients

Sponsor: University of Miami. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07482020: SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

Sponsor: Huashan Hospital. Phase: PHASE2. Conditions: Atrial Fibrillation (AF), Hypertension

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03843359: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Neoplasms

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04980404: Inqovi Maintenance Therapy in Myeloid Neoplasms

Sponsor: Massachusetts General Hospital. Phase: PHASE1. Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05980884: Using Gut Microbial Gbu Gene Testing to Estimate Host TMAO Production Capacity

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Gut Dysbiosis for TMAO Production From L-carnitine Consumption

full page →ctgov ↗
›COMPLETEDphase readoutNCT02071784: Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: CADASIL

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03839784: Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient

Sponsor: Stanford University. Phase: . Conditions: Cognitive Decline, Cognitive Change, Cognitive Impairment, Postoperative Delirium, Anesthesia; Reaction, Anesthesia; Adverse Effect

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06626633: 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML

Sponsor: University of Maryland, Baltimore. Phase: PHASE1. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06608433: Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Healthy Volunteer Study, HPA, Cortisol Deficiency, Adrenal Insufficiency

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07494747: Evaluation of the Effect of the Toothpaste on Delicate Gums

Sponsor: Lacer S.A.. Phase: NA. Conditions: Gingivitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05837949: Multiple Sclerosis Falls Insight Track

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04547049: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE3. Conditions: Leukemia, MDS

full page →ctgov ↗
›COMPLETEDphase readoutNCT07288658: Comparing the Fit and Performance of Scleral Lenses With Oval and Circular Limbal Zones

Sponsor: University of Waterloo. Phase: PHASE4. Conditions: Limbus Corneae

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02043158: Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07227558: Improving Information Sharing Between Family Caregivers and Home Care Aides

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Shared Care

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07341048: Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Polycythemia, Polycythemia Vera (PV)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06008626: Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Sponsor: Cryosa, Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT07139626: Screening of Predictive Biomarkers for Cardiorenal Syndrome

Sponsor: Haiyan Pan. Phase: . Conditions: Cardiorenal Syndrome (CRS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07138885: A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma

Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC), Second Line Treatment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03663543: Intravenous Estrogen in Kidney Transplant Study

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Ischemia Reperfusion Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03962543: MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany. Phase: PHASE2. Conditions: Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT00001215: Genetic Studies of Lysosomal Storage Disorders

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Lysosomal Storage Disorders, Gaucher Disease, Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06572215: DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: Chronic Kidney Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07321535: Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia

Sponsor: Wangjing Hospital, China Academy of Chinese Medical Sciences. Phase: NA. Conditions: Sarcopenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07494708: Hemoglobin Drop and Need for Blood Transfusion in Primary Knee Arthroplasty With or Without Drain Insertion

Sponsor: Shifa International Hospital. Phase: NA. Conditions: Knee Osteoarthritis, Total Knee Arthroplasty

full page →ctgov ↗
›RECRUITINGphase readoutNCT07201376: Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: . Conditions: Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07225725: Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)

Sponsor: University of Tennessee. Phase: NA. Conditions: Head and Neck Neoplasms, Emergency Department Presentation, Head and Neck Cancer (H&N)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07544017: Patient Blood Management in Obstetrics

Sponsor: Corniche Hospital. Phase: . Conditions: Patient Blood Management, Blood Product Transfusion for All Conditions

full page →ctgov ↗
›COMPLETEDphase readoutNCT07516717: Intrathecal Morphine 75 mcg Versus 100 mcg for Post-Cesarean Analgesia: A Randomized Double-blind Trial

Sponsor: Hospital Universitario de Caracas. Phase: PHASE4. Conditions: Postoperative Pain, Cesarean Section, Obstetric Anesthesia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01937468: Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Graft Versus Host Disease, Chronic GVHD, Complications of Organ Transplant Stem Cells

full page →ctgov ↗
← prev
page 69 of 158
next →